clinical trial · NCT06521047
A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial
CellProthera·—·recruiting·n = 48
Acute Myocardial InfarctionNA - Observational study
brief summary
The PERFECT study is an observational study designed to follow patients randomised in the EXCELLENT study (NCT02669810) for 10 years. The aim is to assess the long-term clinical outcomes for patients randomised to the Standard of Care arm or the ProtheraCytes arm.
started
Jul 20, 2024
primary completion
Mar 15, 2034
completion
Mar 15, 2034
last updated
Sep 25, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol